Activity of Afatinib in Patients with NSCLC Harboring Novel Uncommon EGFR Mutations with or Without Co-Mutations: a Case Report
FRONTIERS IN ONCOLOGY（2024）
关键词
EGFR,non-small cell lung cancer (NSCLC),afatinib,uncommon mutation,tyrosine kinase inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要